These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 34926453)
1. Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis. Del Rio D; Masi I; Caprara V; Spadaro F; Ottavi F; Strippoli R; Sandoval P; López-Cabrera M; Sainz de la Cuesta R; Bagnato A; Rosanò L Front Cell Dev Biol; 2021; 9():764375. PubMed ID: 34926453 [TBL] [Abstract][Full Text] [Related]
2. The β-arrestin1/endothelin axis bolsters ovarian fibroblast-dependent invadosome activity and cancer cell metastatic potential. Del Rio D; Masi I; Caprara V; Ottavi F; Albertini Petroni G; Salvati E; Trisciuoglio D; Giannitelli SM; Bagnato A; Mauri E; Spadaro F; Rosanò L Cell Death Dis; 2024 May; 15(5):358. PubMed ID: 38777849 [TBL] [Abstract][Full Text] [Related]
3. The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer. Masi I; Ottavi F; Del Rio D; Caprara V; Vastarelli C; Giannitelli SM; Fianco G; Mozetic P; Buttarelli M; Ferrandina G; Scambia G; Gallo D; Rainer A; Bagnato A; Spadaro F; Rosanò L Cell Death Dis; 2023 Jan; 14(1):73. PubMed ID: 36717550 [TBL] [Abstract][Full Text] [Related]
4. hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process. Di Modugno F; Caprara V; Chellini L; Tocci P; Spadaro F; Ferrandina G; Sacconi A; Blandino G; Nisticò P; Bagnato A; Rosanò L Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3132-3137. PubMed ID: 29439204 [TBL] [Abstract][Full Text] [Related]
5. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer. Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951 [TBL] [Abstract][Full Text] [Related]
8. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737 [TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis. Bagnato A; Rosanò L Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812 [TBL] [Abstract][Full Text] [Related]
10. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer. Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413 [TBL] [Abstract][Full Text] [Related]
11. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer. Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138 [TBL] [Abstract][Full Text] [Related]
12. Mesothelial Cells Participate in Endometriosis Fibrogenesis Through Platelet-Induced Mesothelial-Mesenchymal Transition. Yan D; Liu X; Xu H; Guo SW J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32813013 [TBL] [Abstract][Full Text] [Related]
13. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling. Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497 [TBL] [Abstract][Full Text] [Related]
14. YAP and endothelin-1 signaling: an emerging alliance in cancer. Tocci P; Blandino G; Bagnato A J Exp Clin Cancer Res; 2021 Jan; 40(1):27. PubMed ID: 33422090 [TBL] [Abstract][Full Text] [Related]
15. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy. Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471 [TBL] [Abstract][Full Text] [Related]
16. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer. Rosanò L; Bagnato A J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335 [TBL] [Abstract][Full Text] [Related]